Evidence map›Paper›PMID 19125040›Full record

ArticleEye & contact lens2009

Amoebicidal activities of alexidine against 3 pathogenic strains of acanthamoeba.

Hassan Alizadeh, Sudha Neelam, H Dwight Cavanagh

Abstract read
In one paragraph

Article in Eye & contact lens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Expert review of anti-infective therapy · 2021
    Pooled it
  2. Article
  3. Article
  4. Opportunistic free-living amoebal pathogens.Pathogens and global health · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. The Development of Drugs against Acanthamoeba Infections.Antimicrobial agents and chemotherapy · 2016
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hassan AlizadehDepartment of Ophthalmology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9057, USA. hassan.alizadeh@utsouthwestern.edu
Sudha Neelam
H Dwight Cavanagh
The University of Texas Southwestern Medical Center · US

Funding

BIOLOGY, IMMUNOLOGY &THERAPY OF ACANTHAMOEBA KERATITISR01EY009756 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI ALIZADEH, HASSAN · 1995 to 2013
$3.9M
INFRASTRUCTIRE DEVELOPMENT GRANT FOR CORNEA RESEARCHR24EY016664 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI NIEDERKORN, JERRY · 2005 to 2009
$1.2M
NEI NIH HHS EY09756NEI NIH HHS R01 EY009756NEI NIH HHS R24 EY016664
6 · The paper itself

Abstract

objectivesEffective pharmacotherapy for Acanthamoeba keratitis has been hampered because of the marked resistance of various stains to a variety of antimicrobial agents. In view of the fact that topical Brolene (propamidine isethionate) and neosporin are currently considered to be the first-line medical treatment of choice in Europe, we sought to determine whether Alexidine is equally effective, because the latter drug is more readily available in the United States.

methodsTrophozoites and cysts from 3 pathogenic corneal isolates (A. castellanii, A. polyphaga, and A. rhysodes) were incubated in peptone-yeast extract-glucose medium containing different concentrations of Alexidine for 24 hr. The number of trophozoites was counted by hemocytometer. The cysts were plated in to nonnutrient agar plates precoated with Escherichia coli and observed for viability or excystment over a period of 2 weeks. The capacity of different concentrations of Alexidine to induce cytolysis of corneal epithelial cells was tested in vitro. Chinese hamster corneas were treated with 5 microL of Alexidine topically, every hour; 6 times a day and the corneas were stained with fluorescein to asses the epithelial defects in vivo.

resultsAlexidine was effective in killing the trophozoites at a concentration of 10 microg/mL. However, a higher concentration of Alexidine (100 microg/mL) is required to kill Acanthamoeba cysts and the cytotoxic activities of Alexidine are comparable with chlorhexidine. We have also demonstrated that both Alexidine and chlorhexidine at 100 microg/mL induced significant cytopathic effect on the corneal epithelial cells in vitro. In vivo results indicate that Alexidine at a concentration of 100 microg/mL is less toxic than chlorhexidine when applied topically to the Chinese hamster cornea.

conclusionsOur study has identified Alexidine as a novel anti-Acanthamoeba drug and suggests that Alexidine may be an effective therapeutic option because of its potency and low toxicity to the corneal tissues when applied topically in vivo.

Indexed as

AcanthamoebaAdministration, TopicalAmebiasisAmebicidesAnimalsBiguanidesChlorhexidineCorneaCricetinaeCricetulusDose-Response Relationship, DrugEpithelium, CornealParasitic Sensitivity TestsTrophozoitesalexidineAmebicidesBiguanidesChlorhexidine

Identifiers

PMID19125040
PMCPMC4287276
OpenAlexW1985038976

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.